The FDA has even authorized a drug manufactured with cannabidiol for that reason (Epidiolex). Although the agency only suggests it for 2 exceptional types of childhood epilepsy referred to as Lennox-Gastaut syndrome and Dravet syndrome.In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they intend to reclassify marijuana being